Preventing schizophrenia and psychotic behaviour: Definitions and methodological issues

Canadian Journal of Psychiatry

Volumn 47, Issue 6, 2002, Pages 527-537

  Faraone, Stephen V ^a   Brown, C Hendricks ^a   Glatt, Stephen J ^a   Tsuang, Ming T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Methodology; Premorbid; Prevention; Prodrome; Schizophrenia; Schizotaxia

Indexed keywords

ATTENTION DEFICIT DISORDER; CLINICAL FEATURE; DISEASE PREDISPOSITION; HIGH RISK POPULATION; HUMAN; PRECURSOR; PREGNANCY; PREGNANCY COMPLICATION; PSYCHOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SOCIAL PSYCHOLOGY; VIRUS INFECTION;

EID: 0036695552     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370204700604     Document Type: Review

References (128)

1. Long-term follow-up results of a randomized drug abuse prevention trial in a white middle-class population
2. Examination of preventive interventions for families with depression: Evidence of change
3. Prevention of depression in at-risk samples of adolescents
4. Long-term effects of nurse home visitation on children's criminal and antisocial behavior: 15-Year follow-up of a randomized controlled trial
5. The short-term impact of two classroom based preventive intervention trials on aggressive and shy behaviors and poor achievement
6. Proximal impact of two first-grade preventive interventions on the early risk behaviors for later substance abuse, depression, and antisocial behavior
7. Description and immediate impacts of a preventive intervention for conduct problems
8. A developmental and clinical model for the prevention of conduct disorder: The FAST track program
9. The science of prevention. A conceptual framework and some directions for a national research program
10. Coming to terms with the terms of risk
11. The impact of gender on understanding the epidemiology of schizophrenia
12. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
13. The case for heterogeneity in the etiology of schizophrenia
14. Genetic questions for environmental studies. Differential parenting and psychopathology in adolescence
15. Genetics and psychiatry: An unheralded window on the environment
16. The social ecology of syphilis
17. The UCLA high-risk project
18. "Schizotaxia": Clinical Implications and new directions for research
19. Schizophrenia
20. Epidemiology and behavioral genetics of schizophrenia
21. Overview: A current perspective on twin studies of schizophrenia
22. The types and prevalence of mental illness in the biological and adoptive families of adopted schizophrenics
23. Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen study in the rest of Denmark
24. The frustrating search for schizophrenia genes
25. Quantitative models of the genetic transmission of schizophrenia
26. Linkage strategies for genetically complex traits. I. Multilocus models
27. Schizophrenia and other psychotic disorders
28. Schizophrenia: A review of genetic studies
29. Association between schizophrenia and T 102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene
30. Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia
31. Meta-analysis of DRD3 gene and schizophrenia: Ethnic heterogeneity and significant association in Caucasians
32. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia
33. Association of dopamine D2 receptor molecular variant with schizophrenia
34. Thought disorder in schizophrenic and control adoptees and their relatives
35. Adoption studies of schizophrenia
36. Interaction between genetic vulnerability and family environment: The Finnish adoptive family study of schizophrenia
37. Gene-environment interaction in vulnerability to schizophrenia: Findings from the Finnish adoptive family study in schizophrenia
38. The Finnish adoptive family study of schizophrenia. Implications for family research
39. Comparative birthweights of schizophrenics and their siblings
40. Birthweight and length in schizophrenics, personality disorders and their siblings
41. Perinatal complications in adopted and non-adopted schizophrenics and thier controls: Preliminary results
42. Obstetric factors in the development of schizophrenia: Complications in the births of preschizophrenics and in reproduction by schizophrenic parents
43. Obstetric factors and perinatal injuries
44. Prenatal complications, genetic vulnerability, and schizophrenia: The New England longitudinal studies of schizophrenia
45. Pregnancy/delivery complications and psychiatric diagnosis. A prospective study
46. Genetic and perinatal determinants of structural brain deficits in schizophrenia
47. Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: A 19-year longitudinal study
48. Environmental factors in schizophrenia: New adoption evidence
49. Obstetric complications, the putative familial-sporadic distinction, and tardive dyskinesia in schizophrenia
50. Cerebral ventricular enlargement in non-genetic schizophrenia: A controlled twin study
51. Preinatal complications and genetic loading in schizophrenia: Preliminary findings
52. Obstetric complications in histories of monozygotic twins discordant and concordant for schizophrenia
53. Birth-weight and obstetric complications in schizophrenic twins
54. Biological, psychological and historical differences in a series of monozygotic twins discordant for schizophrenia
55. Obstetric complications and twin studies of schizophrenia: Clarification and affirmation
56. Perinatal complications and reduced size of brain limbic structures in familial schizophrenia
57. Breakdown in individuals at high risk for schizophenia: Possible predispositional perinatal factors
58. Preinatal complications and clinical outcome within the schizophrenia spectrum
59. Schizophrenia and neuroviruses
60. Mental disorder and season of birth
61. The season of birth of siblings of psychiatric patients
62. Clinical and laboratory evidence of autoimmunity in acute schizophrenia
63. Viruses and schizophrenia
64. Abnormal cerebrospinal fluid indices in schizophrenia
65. Assay of interferon and viral antibodies in the cerebrospinal fluid in clinical neurology and psychiatry
66. Elevated levels of soluble interleukin 2 receptors in schizophrenia
67. Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay
68. Spinal fluid monoamine metabolites and anti-cytomegalovirus antibodies and brain scan evaluation in schizophrenia
69. Genetic aspects to the biology of schizophrenia
70. Schizophrenia: Genetics and the maternal immune response to viral infection
71. Adult schizophrenia following prenatal exposure to an influenza epidemic
72. Maternal influenza in the etiology of schizophrenia
73. Schizophrenic births and viral diseases in two states
74. Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study
75. Prenatal influenza and schizophrenia: Is the effect confined to females?
76. Schizophrenia following prenatal exposure to influenza epidemics between 1939 and 1960
77. Prenatal exposure to influenza does not cause schizophrenia
78. The role of gender in identifying subtypes of schizophrenia: A latent class analytic approach
79. Season of birth in schizophrenia. Evidence for confinement of an excess of winter births to patients without a family history of mental disorder
80. Epidemiological and clinical correlates of familial and sporadic schizophrenia
81. Season of birth in high and low genetic risk schizophrenics
82. Risk factors in schizophrenia season of birth, gender, and familial risk
83. Maternal cytokine levels during pregnancy and adult psychosis
84. Maternal infections and subsequent psychosis among offspring
85. An experimental evaluation of theory-based mother and mother-child programs for children of divorce
86. Coping, stress, and the psychological symptoms of children of divorce: A cross-sectional and longitudinal study
87. Two years after a job loss: Long-term impact of the JOBS program on reemployment and mental health
88. Participation in a parent training program for methadone clients
89. Towards the prevention of schizophrenia
90. Infants at risk for schizophrenia: Sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem infant development study
91. Risk factors of psychosis: Identifying vulnerable populations premorbidly
92. Prediction of adult-onset schizophrenia from childhood home movies of the parents
93. Interpersonal behavior of children at risk for schizophrenia
94. Measuring diagnostic accuracy in the absence of a gold standard
95. Sequential strategy to identify a susceptibility gene for schizophrenia: Report of potential linkage on on chromosome 22q12-q13.1. Part I
96. A combined analysis of D22S278 marker alleles in affected sib-pairs: Support for a susceptibility locus at chromosomen 22q12
97. Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22
98. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: Evidence for genetic heterogeneity
99. Additional support for schizophrenia linkage on chromosomes 6 and 8: A multicenter study
100. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
101. Further investigation of a chromosome 15 locus in schizophrenia: Analysis of affected sibpairs from the NIMH Genetics Initiative
102. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by non-parametric linkage analysis
103. Genome scan of European-American schizophrenia pedigrees: Results of the NIMH Genetics Initiative and Millennium Consortium
104. A schizophrenia locus may be located in region 10p15-p11
105. Early intervention for schizophrenia: Can the course of the illness be altered?
106. Early detection and intervention with schizophrenia: Rationale
107. Atypical antipsychotic drugs as a first-line treatment of schizophrenia: A rationale and hypothesis
108. An evolving system of early detection and optimal management
109. Earlier detection and intervention in schizophrenia: Unsolved questions
110. Monitoring and care of young people at incipient risk of psychosis
111. Early detection and intervention for initial episodes of schizophrenia
112. Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients
113. Early detection and intervention in schizophrenia: Research
114. Developmental epidemiology: A framework for developmental psychopathology
115. Overview and summary: Twenty-five-year followup of high-risk children
116. The effect of the level of aggression in the first grade classroom on the course and malleability of aggressive behavior into middle school
117. The increased risk for specific psychiatric disorders among persons of low socioeconomic status
118. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: The NewYork High Risk Project
119. General longitudinal modeling of individual differences in experimental designs: A latent variable framework for analysis and power estimation
120. Principles for designing randomized preventive trials in mental health: An emerging developmental epidemiology paradigm
121. Childhood predictors and the prevention of adolescent substance abuse
122. Developmental changes in attentional performance in urban children from eight to thirteen years
123. Basing preventive interventions on theory: Stimulating a field's momentum
124. Hillside study of risk and early detection in schizophrenia